Kristel PM - Search Results

1

Overexpression of the HER-2 oncogene does not play a role in high-grade osteosarcomas.

Anninga JK, van de Vijver MJ, Cleton-Jansen AM, Kristel PM, Taminiau AH, Nooij M, Egeler RM, Hogendoorn PC. Anninga JK, et al. Among authors: kristel pm. Eur J Cancer. 2004 May;40(7):963-70. doi: 10.1016/j.ejca.2003.10.025. Eur J Cancer. 2004. PMID: 15093570

2

Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers.

Jacobs JJ, Keblusek P, Robanus-Maandag E, Kristel P, Lingbeek M, Nederlof PM, van Welsem T, van de Vijver MJ, Koh EY, Daley GQ, van Lohuizen M. Jacobs JJ, et al. Among authors: kristel p. Nat Genet. 2000 Nov;26(3):291-9. doi: 10.1038/81583. Nat Genet. 2000. PMID: 11062467

3

Determining MDR1/P-glycoprotein expression in breast cancer.

Faneyte IF, Kristel PM, van de Vijver MJ. Faneyte IF, et al. Among authors: kristel pm. Int J Cancer. 2001 Jul 1;93(1):114-22. doi: 10.1002/1097-0215(20010701)93:1<114::aid-ijc1309>3.0.co;2-j. Int J Cancer. 2001. PMID: 11391630 Free article.

4

Expression of the breast cancer resistance protein in breast cancer.

Faneyte IF, Kristel PM, Maliepaard M, Scheffer GL, Scheper RJ, Schellens JH, van de Vijver MJ. Faneyte IF, et al. Among authors: kristel pm. Clin Cancer Res. 2002 Apr;8(4):1068-74. Clin Cancer Res. 2002. PMID: 11948115

5

Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomas.

Robanus-Maandag EC, Bosch CA, Kristel PM, Hart AA, Faneyte IF, Nederlof PM, Peterse JL, van de Vijver MJ. Robanus-Maandag EC, et al. Among authors: kristel pm. J Pathol. 2003 Sep;201(1):75-82. doi: 10.1002/path.1385. J Pathol. 2003. PMID: 12950019

6

Multidrug resistance associated genes MRP1, MRP2 and MRP3 in primary and anthracycline exposed breast cancer.

Faneyte IF, Kristel PM, van de Vijver MJ. Faneyte IF, et al. Among authors: kristel pm. Anticancer Res. 2004 Sep-Oct;24(5A):2931-9. Anticancer Res. 2004. PMID: 15517899 Free article.

7

Gene expression profiles of primary breast carcinomas from patients at high risk for local recurrence after breast-conserving therapy.

Kreike B, Halfwerk H, Kristel P, Glas A, Peterse H, Bartelink H, van de Vijver MJ. Kreike B, et al. Clin Cancer Res. 2006 Oct 1;12(19):5705-12. doi: 10.1158/1078-0432.CCR-06-0805. Clin Cancer Res. 2006. PMID: 17020974

8

Molecular subtypes of breast cancer and amplification of topoisomerase II alpha: predictive role in dose intensive adjuvant chemotherapy.

Hannemann J, Kristel P, van Tinteren H, Bontenbal M, van Hoesel QG, Smit WM, Nooij MA, Voest EE, van der Wall E, Hupperets P, de Vries EG, Rodenhuis S, van de Vijver MJ. Hannemann J, et al. Br J Cancer. 2006 Nov 20;95(10):1334-41. doi: 10.1038/sj.bjc.6603449. Epub 2006 Oct 31. Br J Cancer. 2006. PMID: 17088909 Free PMC article. Clinical Trial.

9

Chromogenic in situ hybridisation for the assessment of HER2 status in breast cancer: an international validation ring study.

van de Vijver M, Bilous M, Hanna W, Hofmann M, Kristel P, Penault-Llorca F, Rüschoff J. van de Vijver M, et al. Breast Cancer Res. 2007;9(5):R68. doi: 10.1186/bcr1776. Breast Cancer Res. 2007. PMID: 17922920 Free PMC article.

10

Integration of DNA copy number alterations and prognostic gene expression signatures in breast cancer patients.

Horlings HM, Lai C, Nuyten DS, Halfwerk H, Kristel P, van Beers E, Joosse SA, Klijn C, Nederlof PM, Reinders MJ, Wessels LF, van de Vijver MJ. Horlings HM, et al. Among authors: kristel p. Clin Cancer Res. 2010 Jan 15;16(2):651-63. doi: 10.1158/1078-0432.CCR-09-0709. Epub 2010 Jan 12. Clin Cancer Res. 2010. PMID: 20068109 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page